About Cannabist

Cannabist is one of the largest and most experienced multi-state operators in the medical cannabis industry, with licenses in 15 jurisdictions in the US and the EU. With over 1.2 million sales transactions since its inception, Cannabist is a patient-centered organization setting the standard for compassion, professionalism, quality, caring and innovation, working in collaboration with some of the most renowned and innovative teaching hospitals and medical centers in the world. The Company is committed to providing the type of education and transparency patients deserve and quality of product that clinicians expect. For more information on Cannabist, please visit or stop by our Bradenton location at 4549 W 14th St W, 34207.

PEOPLE FIRST We aim to restore empathy in medicine to improve patient outcomes and overall health and wellness EXPERT ADVICE

Our patient-centric focus includes one-on-one consultations and follow-ups with pharmacists and experts, enabling individualized care on your personal health and wellness journey.

PRODUCTS WORTHY OF TRUST

With a focus on clean cultivation, superior quality, and positive patient outcomes, we offer brands and products that meet high standards of potency, purity, and predictability.

Our proprietary, patent-pending medical brands define Medical Cannabis. TheraCeed™, ClaraCeed™ and EleCeed™ are pharmaceutical-quality and come in a variety of formats, including hard-pressed tablets, suppositories, vapes, and lotions.

PATIENT TESTIMONIALS

With over one million patient interactions, we’re proud of the positive outcomes we’ve helped create. For powerful stories about how Columbia Care has impacted patients’ lives, click here.

RESEARCH AND DATA Fueling innovation and improving patient outcomes UNIVERSITY PARTNERSHIPS

We have established partnerships with some of the world’s leading research institutions, universities, and medical schools to further medical cannabis research, allowing for timely and relevant data collection and analysis, to drive future innovation.

PROPRIETARY DATA

We analyze patient and research data to identify new insights, that enable innovation in patient care and treatment, leading to new IP and improved patient experiences.

RELENTLESS INNOVATION

From products to service, we innovate to provide better products, patient experiences, and better patient outcomes.

#100MILLION INITIATIVE Cannabist - Leading The Fight Against Opioids

Cannabist is leading the fight against opioid addiction by helping to launch the #100Million initiative. Our CEO Nicholas Vita pledged to take 100 million doses of opioids off the street by leading a nationwide effort to gather the largest data set on how precisely-formulated medical cannabis can be a safe and effective alternative to reduce opioid use for pain.

LEADING THE INDUSTRY Cannabist is leading the industry in product quality and expertise, as well as removing barriers to access for medical cannabis.

From introducing the U.S.’s first legal credit card for cannabis purchases, to starting the 100 million ways to break the opioid crisis research initiative, to advocating for access for patients of all types around the U.S. and the world, we have led the way in this industry and will continue to do so for the good of our business and our patients.

As an experienced multi-state operator, some of our key achievements include six-plus years of strong organic growth, 1 million patient sales transactions, 63 facilities in operation or development, and 39 licenses in 15 markets.

10.08.25 Specials

Never miss a top pick!